Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-na ïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness! registry.
CONCLUSION: This real-world study confirmed the efficacy of anti-VEGF agents in nAMD and the feasibility of analyzing data in an international registry.
PMID: 32622633 [PubMed - as supplied by publisher]
Source: Journal Francais d Ophtalmologie - Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Angiography | Avastin | Blindness | Eyes | France Health | Lucentis | Opthalmology | Ranibizumab Injection | Statistics | Study | Vitamin A